Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD
31.98
+2.60 (8.85%)
Apr 17, 2026, 4:08 PM HKT
HKG:3378 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 614.4 | 161.21 | 162 |
| - | 12.67 | 42.36 |
| 37.76 | - | - |
Cash & Short-Term Investments | 652.17 | 173.88 | 204.36 |
| 275.07% | -14.92% | - |
| 39.66 | 68.91 | 93.9 |
| - | - | 0.5 |
| 691.83 | 242.79 | 298.76 |
Property, Plant & Equipment | 19.95 | 24.13 | 24 |
| 222.96 | 233.78 | 262.39 |
| 0.42 | 0.45 | 0.56 |
| 0.33 | 0.33 | 0.53 |
|
| 18.87 | 12.29 | 12.94 |
| - | 2.8 | 2.56 |
| 30 | - | - |
Current Portion of Leases | 3.52 | 3.17 | 3.2 |
Current Income Taxes Payable | 7.02 | 7.98 | 7.07 |
Other Current Liabilities | 35.71 | 171.2 | 37.11 |
Total Current Liabilities | 95.11 | 197.44 | 62.87 |
| 17 | - | - |
| 5.35 | 8.66 | 11.83 |
Long-Term Deferred Tax Liabilities | 70.4 | 78.77 | 90.47 |
Other Long-Term Liabilities | - | - | 101.49 |
|
| 13.62 | 11.79 | 9.53 |
| - | -72.38 | 0.53 |
Comprehensive Income & Other | 684.12 | 226.83 | 258.07 |
| 697.74 | 166.24 | 268.13 |
| 49.88 | 50.37 | 51.45 |
|
Total Liabilities & Equity | 935.48 | 501.47 | 586.24 |
| 55.86 | 11.83 | 15.03 |
| 596.3 | 162.05 | 189.33 |
| 267.98% | -14.41% | - |
| 5.05 | 14.82 | 25.95 |
Filing Date Shares Outstanding | - | 11.79 | 7.3 |
Total Common Shares Outstanding | - | 11.79 | 7.3 |
| 596.71 | 45.35 | 235.89 |
| - | 14.10 | 36.75 |
| 697.32 | 165.79 | 267.57 |
Tangible Book Value Per Share | - | 14.06 | 36.68 |
| - | 5.14 | 4.1 |
| - | 2.66 | 6.41 |
| - | 8.2 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.